Cervical cancer and the global health agenda: Insights from multiple policy-analysis frameworks.
Cervical cancer is the second leading cause of cancer deaths for women globally, with an estimated 88% of deaths occurring in the developing world. Available technologies have dramatically reduced mortality in high-income settings, yet cervical cancer receives considerably little attention on the global health policy landscape. The authors applied four policy-analysis frameworks to literature on global cervical cancer to explore the question of why cervical cancer may not be receiving the international attention it may otherwise warrant. Each framework explores the process of agenda setting and discerns factors that either facilitate or hinder policy change in cases where there is both a clear problem and a potential effective solution. In combination, these frameworks highlight a number of crucial elements that may be needed to raise the profile of cervical cancer on global health agendas, including improving local (national or sub-national) information on the condition; increasing mobilisation of affected civil society groups; framing cervical cancer debates in ways that build upon its classification as a non-communicable disease (NCD) and an issue of women's rights; linking cervical cancer screening to well-funded services such as those for HIV treatment in some countries; and identifying key global policy windows of opportunity to promote the cervical cancer agenda, including emerging NCD global health discussions and post-2015 reviews of the Millennium Development Goals.
a Department of Global Health and Development , London School of Hygiene and Tropical Medicine , London , UK.
Justin O
JO
Parkhurst
Madhulika
M
Vulimiri
D003906:Developing Countries / Q000191:economics / Q000706:statistics & numerical data; D055088:Early Detection of Cancer / Q000191:economics / Q000592:standards / Q000706:statistics & numerical data; D005260:Female; D014943:Global Health / Q000191:economics / Q000592:standards / Q000706:statistics & numerical data; D007722:Health Knowledge, Attitudes, Practice; D006291:Health Policy; D054624:Health Status Disparities; D006801:Humans; D007391:International Cooperation; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000191:economics; D011050:Policy Making; D012959:Socioeconomic Factors; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D014626:Vaginal Smears / Q000191:economics / Q000706:statistics & numerical data*; D016387:Women's Health / Q000191:economics / Q000592:standards* / Q000706:statistics & numerical data
D053918:Papillomavirus Vaccines